DCM
DTIL icon

Driehaus Capital Management’s Precision BioSciences DTIL Stock Holding History

Driehaus Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.44M Sell
946,707
-48,664
-5% -$342K 0.04% 286
2026
Q1 		$5.47M Buy
995,371
+207,671
+26% +$958K 0.04% 287
2025
Q4 		$3.28M Buy
+787,700
New +$4.47M 0.02% 320

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Driehaus Capital Management's DTIL Position: Q2 2026 in Review

Driehaus Capital Management reduced its Precision BioSciences (DTIL) stake by 4.9% in Q2 2026, selling an estimated $342K and leaving 946,707 shares worth $7.44M. The position accounts for 0.04% of the portfolio, ranked #286.

Driehaus Capital Management first reported a position in DTIL in Q4 2025 and has held it in 3 quarters since. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Driehaus Capital Management held 946,707 shares of Precision BioSciences worth $7.44M as of Q2 2026.
  • Driehaus Capital Management sold 48,664 Precision BioSciences shares in Q2 2026, an estimated $342K.
  • Precision BioSciences made up 0.04% of Driehaus Capital Management's portfolio in Q2 2026, its #286 holding.
  • Driehaus Capital Management first reported a position in Precision BioSciences in Q4 2025 and has held it in 3 quarters since.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.